Founded in 2017
At Antiverse, we are engineering the future of drug discovery. We have developed an Artificial Intelligence (AI)-powered de novo drug discovery platform, which uses hyper-expressing cell lines and machine learning to design antibody candidates against various targets. Our technology facilitates the ...